4'-demethylepipodophyllotoxin has been researched along with glycyrrhetinic acid in 1 studies
| Studies (4'-demethylepipodophyllotoxin) | Trials (4'-demethylepipodophyllotoxin) | Recent Studies (post-2010) (4'-demethylepipodophyllotoxin) | Studies (glycyrrhetinic acid) | Trials (glycyrrhetinic acid) | Recent Studies (post-2010) (glycyrrhetinic acid) |
|---|---|---|---|---|---|
| 39 | 0 | 18 | 102 | 0 | 67 |
| Protein | Taxonomy | 4'-demethylepipodophyllotoxin (IC50) | glycyrrhetinic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 4.9 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Rattus norvegicus (Norway rat) | 0.09 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 0.1853 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Mus musculus (house mouse) | 0.0124 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | Rattus norvegicus (Norway rat) | 0.36 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | Homo sapiens (human) | 0.1035 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 9.6 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 0.5495 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.5248 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for 4'-demethylepipodophyllotoxin and glycyrrhetinic acid
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |